Detection and management of animplantable cardioverter defibrillator lead failure (original) (raw)

Abstract

This study evaluated the long-term reliability of an implantable cardioverter defibrillator (ICD) lead to determine the incidence, clinical presentation, and management of lead failure. BACKGROUND Despite recent advances in ICD technology, the long-term reliability of ICD leads remains a significant problem.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (25)

  1. Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines for implantation of cardiac pacemakers, and antiarrhythmic devices: executive summary-a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation 1998;97:1325-35.
  2. The Antiarrhythmics Versus Implantable Defibrillators (AVID) In- vestigators. A comparison of antiarrhythmic drug therapy with im- plantable defibrillators in patients resuscitated from near fatal ventric- ular arrhythmias. N Engl J Med 1997;337:1576 -83.
  3. Stambler BS, Wood MA, Damiano RJ, Greenway PS, Smutka ML, Ellenbogen KA. Sensing/pacing lead complications with a newer generation implantable cardioverter-defibrillator: a worldwide experi- ence from the Guardian ATP 4210 clinical trial. J Am Coll Cardiol 1994;23:123-32.
  4. Schwartzman D, Nallamothu N, Callans DJ, Preminger MW, Got- tlieb CD, Marchlinski FE. Postoperative lead-related complications in patients with nonthoractomy defibrillation lead systems. J Am Coll Cardiol 1995;25:776 -86.
  5. Gahy GJ, Kleman JM, Wilkoff BL, Morant VA, Pinski SL. Low incidence of lead related complications associated with non- thoracotomy implantable cardioverter defibrillator systems. Pacing Clin Electrophysiol 1995;18:172-8.
  6. Lawton JS, Ellenbogen KA, Wood MA, et al. Sensing lead-related complications in patients with transvenous implantable cardioverter- defibrillators. Am J Cardiol 1996;78:647-51.
  7. Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with pectoral implantation of cardioverter defibrillators: world-wide jewel investigators. Pacing Clin Electrophysiol 1997;20: 208 -11.
  8. Degertu FT, Khalighi K, Peters RW, Shorofsky SR, Gold MR. Sensing lead failure in implantable defibrillators: a comparison of two commonly used leads. J Cardiovasc Electrophysiol 2000;11:21-4.
  9. Tyers GF, Sanders R, Jacqmein W. Reliability of coated wire defibril- lation leads. Pacing Clin Electrophysiol 1999;22:174 -8.
  10. Luria D, Glikson M, Brady PA, et al. Predictors and mode of detection of transvenous lead malfunction in implantable defibrillators. Am J Cardiol 2001;87:901-4.
  11. Kron J, Herre J, Renfroe EG, et al. Lead-and device-related complications in the antiarrhythmics versus implantable defibrillators trial. Am Heart J 2001;141:92-8.
  12. Mehta D, Nayak HM, Singson M, et al. Late complications in patients with pectoral defibrillator implants with transvenous defibril- lator lead systems: high incidence of insulation breakdown. Pacing Clin Electrophysiol 1998;21:1893-900.
  13. Lawton JS, Wood MA, Gilligan DM, Stambler BS, Damiano RJ Jr., Ellenbogen KA. Implantable transvenous cardioverter defibrillator leads: the dark side. Pacing Clin Electrophysiol 1996;19:1273-8.
  14. Korte T, Jung W, Spehl S, et al. Incidence of ICD lead related complications during long-term follow-up: comparison of epicardial and endocardial electrode systems. Pacing Clin Electrophysiol 1995; 18:2053-61.
  15. Bracke FALE, Meijer A, van Gelder LM. Malfunction of endocardial defibrillator leads and lead extraction: where do they meet? Europace 2002;4:19 -24.
  16. Bardy GH, Yee R, Jung W. Multicenter experience with a pectoral implantable cardioverter-defibrillator: Active Canadian investigators. J Am Coll Cardiol 1996;28:400 -10.
  17. Roelke M, O'Nunain SS, Osswald S, Garan H, Harthorne JW, Ruskin JN. Subclavian crush syndrome complicating transvenous cardioverter defibrillator systems. Pacing Clin Electrophysiol 1995;18: 973-9.
  18. Hauser RG, Cannom D, Hayes DL, et al. Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol 2002;25:879 -82.
  19. Gunderson B, Wood N, Pearson A, Wang W, Olson W. A new sensing integrity indicator for ventricular pace/sense leads. Pacing Clin Electrophysiol 2000;23:591.
  20. Medtronic Inc. ICD Lead Survival Analysis. Tachyarrhythmia Prod- uct Performance Report. 2nd ed. Fridley, MN: Medtronic, 2001.
  21. Hayes DL, Graham KJ, Irwin M, et al. Multicenter experience with a bipolar tined polyurethane ventricular lead. Pacing Clin Electrophysiol 1995;18:999 -1004.
  22. Antonelli D, Rosenfeld T, Freedberg NA, Palma E, Gross JN, Furman S. Insulation lead malfunction: is it a matter of insulation coating, venous approach, or both? Pacing Clin Electrophysiol 1998; 21:418 -21.
  23. Mond HG. Engineering and clinical aspects of pacing leads. In: Ellenbogen KA, Kay GN, Wilkoff BL, editors. Clinical Cardiac Pacing and Defibrillation. Philadelphia, PA: WB Saunders Company, 2000:127-50.
  24. Bardy GH, Cappato R, Smith WM, et al. The totally subcutaneous ICD system (the S-ICD) (abstr). Pacing Clin Electrophysiol 2002;24: 578. 80 Ellenbogen et al. JACC Vol. 41, No. 1, 2003
  25. Long-Term Failure of ICD Leads January 1, 2003:73-80